Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants

Acta Obstetricia et Gynecologica Scandinavica

Volumn 76, Issue 8, 1997, Pages 733-738

  Gottvall, Tomas ^a   Hildén, Jan Olof ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amniotic fluid bilirubin content ( OD450 (nm)); Anti D antibody concentration; Anti D antibody titers; Hemolytic disease of the newborn (HDN); Rh(D) alloimmunized pregnancies

Indexed keywords

BILIRUBIN; HEMOGLOBIN; RHESUS D ANTIBODY;

ACCURACY; ALLOIMMUNITY; AMNION FLUID; ANEMIA; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BILIRUBIN BLOOD LEVEL; COOMBS TEST; COVARIANCE; FEMALE; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MATERNAL SERUM; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PREDICTION; PREGNANCY; PRIORITY JOURNAL;

EID: 0030924402     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349709024338     Document Type: Article

References (29)

1. Frazer ID, Tovey GH. Observations on Rh iso-immunization: past, present and future. Clin Haematol 1976; 5(1): 149-63.
2. Bowman JM, Pollock J. Rh immunization in Manitoba: progress in prevention and management. Can Med Assoc J 1983; 129: 343-5.
3. McMaster Conference on prevention of Rh immunization.Vox Sang 1979; 36: 50-64.
4. Bowman JM. The prevention of Rh immunization. In: Transfus Med Rev, Vol. 2, No. 3, 1983: 129-50.
5. Gottvall T, Hildén JO, Selbing A. Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newborn. Acta Obstet Gynecol Scand 1994; 73: 300-6.
6. Jacobs WM. Fetal survival rates in Rh-immunized gravidas: correlation of antibody titers and past obstetric history. Obstet Gynecol 1962; 19: 806-7.
7. Tovey LAD. Rh hemolytic disease of the newborn: the role of the laboratory. Med Lab Sci 1982; 39: 297-303.
8. Judd WJ, Luban NLC, Ness PM, Silberstein LE, Stroup M, Widmann FK. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 1990; 30(2): 175-83.
9. Liley AW. Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization. Am J Obstet Gynecol 1961; 82: 1359-70.
10. Queenan JT, Tomai TP, Ural SH, King JC. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation. A proposal for clinical management. Am J Obstet Gynecol 1993; 168: 1370-6.
11. MacKenzie IZ, Bowell PJ, Castle BM, Selinger M, Ferguson JF. Serial fetal blood sampling for the management of pregnancies complicated by severe rhesus (D) isoimmunization. Br J Obstet Gynaecol 1988; 95: 753-8.
12. Peddle LJ. Increase of antibody titer following amniocentesis. Am J Obstet Gynecol 1968; 100: 567.
13. Bowman JM, Pollock JM. Transplacental fetal hemorrhage after amniocentesis. Obstet Gynecol 1985; 66: 749-54.
14. Bowell PJ, Selinger M, Fergusson J, Giles J, MacKenzie IZ. Antenatal fetal blood sampling for the management of alloimmunized pregnancies: effect upon maternal anti-D potency levels. Br J Obstet Gynaecol 1988; 95: 759-64.
15. Ghidini A, Sepulveda W, Lockwood CJ, Romero R. Complications of fetal blood sampling. Am J Obstet Gynecol 1993; 168: 1339-44.
16. Hughes-Jones NC. The estimation of the concentration and equilibrium constant of anti-D. Immunology 1967; 12: 565.
17. Moore BPL. Automation in the blood transfusion laboratory: I. Antibody detection and quantitation in the Technicon AutoAnalyzer. Can Med Assoc J 1969; 100: 381.
18. Bowell PJ, Wainscoat JS, Peto TEA. AutoAnalyzer anti-D measurement and outcome of Rhesus-sensitized pregnancies: Serum analysis. Plasma Ther Transfus Technol 1984; 5: 81-5.
19. Nicolaides KH, Rodeck CH. Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunization. Br Med J 1992; 304: 1155-6.
20. Economides DL, Bowell PJ, Selinger M, Pratt GA, Ferguson J, MacKenzie IZ. Anti-D concentrations in fetal and maternal serum and amniotic fluid in rhesus allo-immunised pregnancies. Br J Obstet Gynaecol 1993; 100: 923-6.
21. Gottvall T, Selbing A, Hildén JO. Evaluation of a new Swedish protocol for alloimmunization screening during pregnancy. Acta Obstet Gynecol Scand 1993; 72: 434-8.
22. Issitt PD. In: Applied blood group serology. 3rd ed. Miami: Montgomery Scientific Publication, 1985: 60-1.
23. Perrault R, Högman C. Automated red cell antibody analysis. A parallel study I. Detection and quantitation. Vox Sang 1971; 20: 340-55.
24. Diamond LK, Allen FA Jr, Thomas WO Jr. Erythroblastosis fetalis. VII. Treatment with exchange transfusion. New Engl J Med 1951; 244(2): 39-49.
25. Pridmore BR, Robertson EG, Walker W. Liquor bilirubin levels and false prediction of severity in rhesus haemolytic disease. Br Med J 1972; ii: 136-9.
26. Bowman JM. The management of Rhesus-isoimmunization. Obstet Gynecol 1978; 52: 1-16.
27. Weiner S, Bolognese RJ, Librizzi RJ. Ultrasound in the evaluation and management of the isoimmunized pregnancy. J Clin Ultrasound 1981; 9: 315-23.
28. Frigoletto FD, Greene MF, Benacerraf BR, Barss VA, Saltzman DH. Ultrasonographic fetal surveillance in the management of the isoimmunized pregnancy. N Engl J Med 1986; 315: 430-2.
29. Filbey D, Berseus O, Sandström B, Wesström G. The evaluation of maternal anti-D concentrations during pregnancy. Early Hum Dev 1987; 15: 1-9.